Inovio Pharmaceuticals Inc. logo

Inovio Pharmaceuticals Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

2.37
 
USD
  
0.09
  
(3.95%)
Optionable: Yes  Market Cap: 472 M  90-day average vol: 7,138,202

Previous close: 2.28  Open: 2.2  Bid: 2.44  Ask: 2.44
52 week range    
1.38   
   9.96
Peers   
PFE / 
JNJ / 
ARWR / 
NVS / 
MRK / 
DRRX / 
GILD / 
Last updated: Monday 8th August 2022
48
MarketXLS Rank marketxls
60
Value marketxls
53
Technical marketxls
31
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ARWR

6 B-38.852.1

DRRX

0 B-6.90.723

GILD

0.044486 B11.763.76

GSK

JNJ

0.0247450 B22.1171.06

MRK

0.0356207 B28.877.58

NVS

PFE

0.0302298 B15.153.21
Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 46.037


Financials

INO Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues4 M13 M10 M41 M35 M42 M30 M4 M7 M2 M
Cost of sales-2 M-2 M-2 M-2 M-3 M-4 M-5 M-6 M-5 M-6 M
Gross operating profit66000310 M8 M28 M8 M29 M30 M4 M7 M1 M
Selling Gen & administrative expense11 M14 M16 M18 M24 M28 M29 M27 M37 M54 M
Research & development expense18 M21 M34 M58 M89 M99 M95 M88 M94 M249 M
Operating income-25 M-22 M-39 M-35 M-77 M-85 M-94 M-111 M-124 M-301 M
floaterest income0000000000
floaterest expense0000000000
Other income net5 M-45 M3 M4 M2 M-5 M-3 M-4 M-33 M-3 M
Pre-tax Income (EBT)-20 M-66 M-36 M-31 M-74 M-88 M-95 M-121 M-163 M-303 M
Income taxes000-2 M002 M-25733500
Net income from total operations-20 M-66 M-36 M-29 M-74 M-88 M-97 M-121 M-167 M-304 M
Minority floaterest0000000000
Total net income-20 M-66 M-36 M-29 M-74 M-88 M-97 M-119 M-166 M-304 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-20 M-66 M-36 M-29 M-74 M-88 M-97 M-121 M-167 M-304 M
Depreciation2 M2 M2 M2 M3 M4 M5 M6 M5 M6 M
Amortization0000000000
Operating income before depreciation (EBITDA)-23 M-19 M-38 M-33 M-74 M-85 M-90 M-107 M-150 M-297 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-0.56-1.44-0.61-0.43-1.01-1.08-1.05-1.21-1.07-1.45
Diluted EPS total-0.56-1.44-0.64-0.44-1.01-1.09-1.05-1.21-1.07-1.45
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!